Choroidal Neovascularization Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
The global choroidal neovascularization market size reached US$ 6.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.5 Billion by 2028, exhibiting a growth rate (CAGR) of 8.0% during 2022-2028.
Choroidal neovascularization (CNV) refers to the creation of new blood vessels in the choroid layer of the eyes affecting the Bruch's membrane and retinal pigment epithelium (RPE). Its symptoms include lipid exudation, subretinal blood and fluid, and distortion, waviness and black spots in the central vision. At present, a combination of procedures, such as fluorescein angiography (FA), indocyanine green (ICG) angiography and optical coherence tomography (OCT) scanning, are utilized for diagnosing CNV. As per the results, doctors then prescribe anti-vascular endothelial growth factor (VEGF) drugs, thermal laser treatment and photodynamic therapy (PDT), to prevent the growth of the blood vessels.
The market is experiencing growth on account of the rising prevalence of age-related macular degeneration (ARMD), ocular histoplasmosis, pathologic myopia, angioid streaks, choroidal tears and inflammatory diseases of the choroid and retina. Moreover, the increasing geriatric population, which is more vulnerable to serious health conditions, is acting as another key factor bolstering the market growth. Furthermore, the growing adoption of combination drugs, along with the introduction of long-lasting anti-VEGF drugs, is propelling the demand for CNV treatments worldwide. Other factors, such as improving healthcare infrastructure and the increasing investments in research and development (R&D) activities, are also contributing to the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global choroidal neovascularization market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, type of diagnosis, treatment type and application.
Breakup by Product Type:
Intravenous
Intravitreal
Breakup by Type of Diagnosis:
Fluorescein Angiography (FA)
Indocyanine Green (ICG) Angiography
Spectral Domain Optical Coherence Tomography (OCT)
Others
Breakup by Treatment Type:
Angiogenesis Inhibitors Injection
Photodynamic Therapy
Laser photocoagulation
Low-dose Radiation Therapy
Surgery
Breakup by Application:
Extreme Myopia
Malignant Myopic Degeneration
Age-Related Developments
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Bausch Health Companies Inc., Bayer AG, Gilead Sciences, Inc., F. Hoffmann-La Roche AG, MaaT Pharma, Novartis AG, Pfizer Inc., Quark Pharmaceuticals Inc. (SBI ALApharma Co. Limited), Regeneron Pharmaceuticals Inc. and Sanwa Kagaku Kenkyusho Co. Ltd. (Suzuken Co. Ltd.).
Key Questions Answered in This Report:
How has the global choroidal neovascularization market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global choroidal neovascularization market?
What are the key regional markets?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the type of diagnosis?
What is the breakup of the market based on the treatment type?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global choroidal neovascularization market and who are the key players?
What is the degree of competition in the industry?
Choroidal neovascularization (CNV) refers to the creation of new blood vessels in the choroid layer of the eyes affecting the Bruch's membrane and retinal pigment epithelium (RPE). Its symptoms include lipid exudation, subretinal blood and fluid, and distortion, waviness and black spots in the central vision. At present, a combination of procedures, such as fluorescein angiography (FA), indocyanine green (ICG) angiography and optical coherence tomography (OCT) scanning, are utilized for diagnosing CNV. As per the results, doctors then prescribe anti-vascular endothelial growth factor (VEGF) drugs, thermal laser treatment and photodynamic therapy (PDT), to prevent the growth of the blood vessels.
The market is experiencing growth on account of the rising prevalence of age-related macular degeneration (ARMD), ocular histoplasmosis, pathologic myopia, angioid streaks, choroidal tears and inflammatory diseases of the choroid and retina. Moreover, the increasing geriatric population, which is more vulnerable to serious health conditions, is acting as another key factor bolstering the market growth. Furthermore, the growing adoption of combination drugs, along with the introduction of long-lasting anti-VEGF drugs, is propelling the demand for CNV treatments worldwide. Other factors, such as improving healthcare infrastructure and the increasing investments in research and development (R&D) activities, are also contributing to the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global choroidal neovascularization market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, type of diagnosis, treatment type and application.
Breakup by Product Type:
Intravenous
Intravitreal
Breakup by Type of Diagnosis:
Fluorescein Angiography (FA)
Indocyanine Green (ICG) Angiography
Spectral Domain Optical Coherence Tomography (OCT)
Others
Breakup by Treatment Type:
Angiogenesis Inhibitors Injection
Photodynamic Therapy
Laser photocoagulation
Low-dose Radiation Therapy
Surgery
Breakup by Application:
Extreme Myopia
Malignant Myopic Degeneration
Age-Related Developments
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Bausch Health Companies Inc., Bayer AG, Gilead Sciences, Inc., F. Hoffmann-La Roche AG, MaaT Pharma, Novartis AG, Pfizer Inc., Quark Pharmaceuticals Inc. (SBI ALApharma Co. Limited), Regeneron Pharmaceuticals Inc. and Sanwa Kagaku Kenkyusho Co. Ltd. (Suzuken Co. Ltd.).
Key Questions Answered in This Report:
How has the global choroidal neovascularization market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global choroidal neovascularization market?
What are the key regional markets?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the type of diagnosis?
What is the breakup of the market based on the treatment type?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global choroidal neovascularization market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL CHOROIDAL NEOVASCULARIZATION MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT TYPE
6.1 Intravenous
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Intravitreal
6.2.1 Market Trends
6.2.2 Market Forecast
7 MARKET BREAKUP BY TYPE OF DIAGNOSIS
7.1 Fluorescein Angiography (FA)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Indocyanine Green (ICG) Angiography
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Spectral Domain Optical Coherence Tomography (OCT)
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 MARKET BREAKUP BY TREATMENT TYPE
8.1 Angiogenesis Inhibitors Injection
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Photodynamic Therapy
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Laser Photocoagulation
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Low-dose Radiation Therapy
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Surgery
8.5.1 Market Trends
8.5.2 Market Forecast
9 MARKET BREAKUP BY APPLICATION
9.1 Extreme Myopia
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Malignant Myopic Degeneration
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Age-Related Developments
9.3.1 Market Trends
9.3.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Bausch Health Companies Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Bayer AG
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Gilead Sciences, Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 F. Hoffmann-La Roche AG
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 SWOT Analysis
15.3.5 MaaT Pharma
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Novartis AG
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Pfizer Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Quark Pharmaceuticals Inc. (SBI ALApharma Co., Limited)
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Regeneron Pharmaceuticals Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Sanwa Kagaku Kenkyusho Co. Ltd. (SUZUKEN CO., LTD.)
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL CHOROIDAL NEOVASCULARIZATION MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT TYPE
6.1 Intravenous
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Intravitreal
6.2.1 Market Trends
6.2.2 Market Forecast
7 MARKET BREAKUP BY TYPE OF DIAGNOSIS
7.1 Fluorescein Angiography (FA)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Indocyanine Green (ICG) Angiography
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Spectral Domain Optical Coherence Tomography (OCT)
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 MARKET BREAKUP BY TREATMENT TYPE
8.1 Angiogenesis Inhibitors Injection
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Photodynamic Therapy
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Laser Photocoagulation
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Low-dose Radiation Therapy
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Surgery
8.5.1 Market Trends
8.5.2 Market Forecast
9 MARKET BREAKUP BY APPLICATION
9.1 Extreme Myopia
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Malignant Myopic Degeneration
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Age-Related Developments
9.3.1 Market Trends
9.3.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Bausch Health Companies Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Bayer AG
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Gilead Sciences, Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 F. Hoffmann-La Roche AG
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 SWOT Analysis
15.3.5 MaaT Pharma
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Novartis AG
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Pfizer Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Quark Pharmaceuticals Inc. (SBI ALApharma Co., Limited)
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Regeneron Pharmaceuticals Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Sanwa Kagaku Kenkyusho Co. Ltd. (SUZUKEN CO., LTD.)
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
LIST OF TABLES
Table 1: Global: Choroidal Neovascularization Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Choroidal Neovascularization Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
Table 3: Global: Choroidal Neovascularization Market Forecast: Breakup by Type of Diagnosis (in Million US$), 2023-2028
Table 4: Global: Choroidal Neovascularization Market Forecast: Breakup by Treatment Type (in Million US$), 2023-2028
Table 5: Global: Choroidal Neovascularization Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 6: Global: Choroidal Neovascularization Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Choroidal Neovascularization Market Structure
Table 8: Global: Choroidal Neovascularization Market: Key Players
Table 1: Global: Choroidal Neovascularization Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Choroidal Neovascularization Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
Table 3: Global: Choroidal Neovascularization Market Forecast: Breakup by Type of Diagnosis (in Million US$), 2023-2028
Table 4: Global: Choroidal Neovascularization Market Forecast: Breakup by Treatment Type (in Million US$), 2023-2028
Table 5: Global: Choroidal Neovascularization Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 6: Global: Choroidal Neovascularization Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Choroidal Neovascularization Market Structure
Table 8: Global: Choroidal Neovascularization Market: Key Players
LIST OF FIGURES
Figure 1: Global: Choroidal Neovascularization Market: Major Drivers and Challenges
Figure 2: Global: Choroidal Neovascularization Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Choroidal Neovascularization Market: Breakup by Product Type (in %), 2022
Figure 4: Global: Choroidal Neovascularization Market: Breakup by Type of Diagnosis (in %), 2022
Figure 5: Global: Choroidal Neovascularization Market: Breakup by Treatment Type (in %), 2022
Figure 6: Global: Choroidal Neovascularization Market: Breakup by Application (in %), 2022
Figure 7: Global: Choroidal Neovascularization Market: Breakup by Region (in %), 2022
Figure 8: Global: Choroidal Neovascularization Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 9: Global: Choroidal Neovascularization (Intravenous) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Choroidal Neovascularization (Intravenous) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Choroidal Neovascularization (Intravitreal) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Choroidal Neovascularization (Intravitreal) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Choroidal Neovascularization (Fluorescein Angiography) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Choroidal Neovascularization (Fluorescein Angiography) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Choroidal Neovascularization (Indocyanine Green Angiography) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Choroidal Neovascularization (Indocyanine Green Angiography) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Choroidal Neovascularization (Spectral Domain Optical Coherence Tomography) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Choroidal Neovascularization (Spectral Domain Optical Coherence Tomography) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Choroidal Neovascularization (Other Type of Diagnosis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Choroidal Neovascularization (Other Type of Diagnosis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Choroidal Neovascularization (Angiogenesis Inhibitors Injection) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Choroidal Neovascularization (Angiogenesis Inhibitors Injection) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Choroidal Neovascularization (Photodynamic Therapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Choroidal Neovascularization (Photodynamic Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Choroidal Neovascularization (Laser photocoagulation) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Choroidal Neovascularization (Laser photocoagulation) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Choroidal Neovascularization (Low-dose Radiation Therapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Choroidal Neovascularization (Low-dose Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Choroidal Neovascularization (Surgery) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Choroidal Neovascularization (Surgery) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Choroidal Neovascularization (Extreme Myopia) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Choroidal Neovascularization (Extreme Myopia) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Choroidal Neovascularization (Malignant Myopic Degeneration) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Choroidal Neovascularization (Malignant Myopic Degeneration) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Choroidal Neovascularization (Age-Related Developments) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Choroidal Neovascularization (Age-Related Developments) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: North America: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: North America: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: United States: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: United States: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Canada: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Canada: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Asia Pacific: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Asia Pacific: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: China: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: China: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Japan: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Japan: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: India: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: India: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: South Korea: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: South Korea: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Australia: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Australia: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Indonesia: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Indonesia: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Others: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Europe: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Europe: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Germany: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Germany: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: France: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: France: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: United Kingdom: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: United Kingdom: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Italy: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Italy: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Spain: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Spain: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Russia: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Russia: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Others: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Latin America: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Latin America: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Brazil: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Brazil: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Mexico: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Mexico: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Others: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Middle East and Africa: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Middle East and Africa: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Global: Choroidal Neovascularization Industry: SWOT Analysis
Figure 86: Global: Choroidal Neovascularization Industry: Value Chain Analysis
Figure 87: Global: Choroidal Neovascularization Industry: Porter’s Five Forces Analysis
Figure 1: Global: Choroidal Neovascularization Market: Major Drivers and Challenges
Figure 2: Global: Choroidal Neovascularization Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Choroidal Neovascularization Market: Breakup by Product Type (in %), 2022
Figure 4: Global: Choroidal Neovascularization Market: Breakup by Type of Diagnosis (in %), 2022
Figure 5: Global: Choroidal Neovascularization Market: Breakup by Treatment Type (in %), 2022
Figure 6: Global: Choroidal Neovascularization Market: Breakup by Application (in %), 2022
Figure 7: Global: Choroidal Neovascularization Market: Breakup by Region (in %), 2022
Figure 8: Global: Choroidal Neovascularization Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 9: Global: Choroidal Neovascularization (Intravenous) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Choroidal Neovascularization (Intravenous) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Choroidal Neovascularization (Intravitreal) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Choroidal Neovascularization (Intravitreal) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Choroidal Neovascularization (Fluorescein Angiography) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Choroidal Neovascularization (Fluorescein Angiography) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Choroidal Neovascularization (Indocyanine Green Angiography) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Choroidal Neovascularization (Indocyanine Green Angiography) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Choroidal Neovascularization (Spectral Domain Optical Coherence Tomography) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Choroidal Neovascularization (Spectral Domain Optical Coherence Tomography) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Choroidal Neovascularization (Other Type of Diagnosis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Choroidal Neovascularization (Other Type of Diagnosis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Choroidal Neovascularization (Angiogenesis Inhibitors Injection) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Choroidal Neovascularization (Angiogenesis Inhibitors Injection) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Choroidal Neovascularization (Photodynamic Therapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Choroidal Neovascularization (Photodynamic Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Choroidal Neovascularization (Laser photocoagulation) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Choroidal Neovascularization (Laser photocoagulation) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Choroidal Neovascularization (Low-dose Radiation Therapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Choroidal Neovascularization (Low-dose Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Choroidal Neovascularization (Surgery) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Choroidal Neovascularization (Surgery) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Choroidal Neovascularization (Extreme Myopia) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Choroidal Neovascularization (Extreme Myopia) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Choroidal Neovascularization (Malignant Myopic Degeneration) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Choroidal Neovascularization (Malignant Myopic Degeneration) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Choroidal Neovascularization (Age-Related Developments) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Choroidal Neovascularization (Age-Related Developments) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: North America: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: North America: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: United States: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: United States: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Canada: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Canada: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Asia Pacific: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Asia Pacific: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: China: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: China: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Japan: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Japan: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: India: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: India: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: South Korea: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: South Korea: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Australia: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Australia: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Indonesia: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Indonesia: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Others: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Europe: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Europe: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Germany: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Germany: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: France: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: France: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: United Kingdom: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: United Kingdom: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Italy: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Italy: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Spain: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Spain: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Russia: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Russia: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Others: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Latin America: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Latin America: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Brazil: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Brazil: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Mexico: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Mexico: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Others: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Middle East and Africa: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Middle East and Africa: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Global: Choroidal Neovascularization Industry: SWOT Analysis
Figure 86: Global: Choroidal Neovascularization Industry: Value Chain Analysis
Figure 87: Global: Choroidal Neovascularization Industry: Porter’s Five Forces Analysis
